PharmaCielo Ltd. (PCLO.V)

CAD 0.09

(0.0%)

Total Liabilities Summary of PharmaCielo Ltd.

PharmaCielo Ltd.'s latest annual total liabilities in 2023 was 23.96 Million CAD , up 28.01% from previous year.
PharmaCielo Ltd.'s latest quarterly total liabilities in 2024 Q2 was 25.95 Million CAD , up 1.93% from previous quarter.
PharmaCielo Ltd. reported annual total liabilities of 18.72 Million CAD in 2022, up 12.58% from previous year.
PharmaCielo Ltd. reported annual total liabilities of 16.63 Million CAD in 2021, down -6.45% from previous year.
PharmaCielo Ltd. reported quarterly total liabilities of 25.95 Million CAD for 2024 Q2, up 1.93% from previous quarter.
PharmaCielo Ltd. reported quarterly total liabilities of 23.85 Million CAD for 2023 Q3, up 7.12% from previous quarter.

Annual Total Liabilities Chart of PharmaCielo Ltd. (2023 - 2017)

Historical Annual Total Liabilities of PharmaCielo Ltd. (2023 - 2017)

Year	Total Liabilities	Total Liabilities Growth
2023	23.96 Million CAD	28.01%
2022	18.72 Million CAD	12.58%
2021	16.63 Million CAD	-6.45%
2020	17.77 Million CAD	275.76%
2019	4.73 Million CAD	20779.39%
2018	22.65 Thousand CAD	79.19%
2017	12.64 Thousand CAD	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q1	25.46 Million CAD	6.25%
2024 Q2	25.95 Million CAD	1.93%
2023 Q3	23.85 Million CAD	7.12%
2023 Q4	23.96 Million CAD	0.48%
2023 FY	23.96 Million CAD	28.01%
2023 Q1	20.88 Million CAD	11.53%
2023 Q2	22.27 Million CAD	6.64%
2022 FY	18.72 Million CAD	12.58%
2022 Q2	15.97 Million CAD	6.25%
2022 Q1	15.02 Million CAD	-9.63%
2022 Q4	18.72 Million CAD	4.35%
2022 Q3	17.94 Million CAD	12.36%
2021 Q1	16.73 Million CAD	-5.88%
2021 FY	16.63 Million CAD	-6.45%
2021 Q4	16.63 Million CAD	16.33%
2021 Q3	14.29 Million CAD	2.13%
2021 Q2	13.99 Million CAD	-16.34%
2020 Q2	7.73 Million CAD	29.35%
2020 Q4	17.77 Million CAD	208.7%
2020 FY	17.77 Million CAD	275.76%
2020 Q1	5.98 Million CAD	26.43%
2020 Q3	5.75 Million CAD	-25.57%
2019 Q3	7.45 Million CAD	14.04%
2019 Q2	6.54 Million CAD	83.2%
2019 Q1	3.57 Million CAD	12635.33%
2019 FY	4.73 Million CAD	20779.39%
2019 Q4	4.73 Million CAD	-36.57%
2018 Q3	22.65 Thousand CAD	-25.48%
2018 Q1	30.98 Thousand CAD	81.5%
2018 Q2	30.4 Thousand CAD	-1.88%
2018 Q4	28.03 Thousand CAD	23.72%
2018 FY	22.65 Thousand CAD	79.19%
2017 Q4	17.07 Thousand CAD	0.0%
2017 FY	12.64 Thousand CAD	0.0%

Peer Total Liabilities Comparison of PharmaCielo Ltd.

Name	Total Liabilities	Total Liabilities Difference
Aequus Pharmaceuticals Inc.	5.38 Million CAD	-345.515%
CanadaBis Capital Inc.	15.61 Million CAD	-53.462%
Decibel Cannabis Company Inc.	96.79 Million CAD	75.236%
Delivra Health Brands Inc.	4.85 Million CAD	-393.393%
Entourage Health Corp.	178.68 Million CAD	86.586%
Lifeist Wellness Inc.	9.94 Million CAD	-141.12%
Cannara Biotech Inc.	61.77 Million CAD	61.202%
Medicure Inc.	8.16 Million CAD	-193.63%
Rubicon Organics Inc.	16.99 Million CAD	-41.021%
BioSyent Inc.	6.76 Million CAD	-254.09%
Voyageur Pharmaceuticals Ltd.	727.87 Thousand CAD	-3193.003%